Anthrax meningoencephalitis successfully treated.
M
M
Bindu
B
B
Vengamma
G
G
Kumar
D000368:Aged; D000881:Anthrax / Q000150:complications* / Q000188:drug therapy; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001408:Bacillus anthracis / Q000187:drug effects / Q000302:isolation & purification; D001929:Brain Edema / Q000139:chemically induced / Q000000981:diagnostic imaging / Q000503:physiopathology; D002438:Cefoperazone / Q000627:therapeutic use; D002555:Cerebrospinal Fluid / Q000166:cytology / Q000382:microbiology; D002939:Ciprofloxacin / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005334:Fever / Q000382:microbiology / Q000503:physiopathology; D006801:Humans; D008297:Male; D008590:Meningoencephalitis / Q000188:drug therapy / Q000382:microbiology* / Q000503:physiopathology*; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome; D014474:Unconsciousness / Q000382:microbiology / Q000503:physiopathology
D000900:Anti-Bacterial Agents; D002939:Ciprofloxacin; D002438:Cefoperazone